Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.
Press releases published on April 3, 2025
自由的國際化城市 (Free Global Cities)：將移民危機化為良機的新願景
GlobeNewswire
·
April 3, 2025
蘇黎世, April 03, 2025 (GLOBE NEWSWIRE) -- 由於傳統方法未能奏效，《自由的國際化城市：移民和公共管治的未來領導者》 (Free Global Cities: The Future Leaders in Migration and Public Governance) 提出了一個大膽的替代方案：建立自治城市，旨在帶來經濟發展機會，並且推動教育和創新。 這本書由瑞士非牟利人道主義組織 Andan Foundation 的主席 Christian H. Kälin 博士 …
big xyt Announces Formal Bid for European Consolidated Tape Provider with Widespread Industry Support
GlobeNewswire
·
April 3, 2025
London, April 03, 2025 (GLOBE NEWSWIRE) -- big xyt, a leading independent provider of high-quality European trade data and analytics, today announced its formal intent to become the official provider of the EU Consolidated Tape (CT) for equities and ETFs. …
Axi launches ‘Four Years’ campaign with Manchester City stars
GlobeNewswire
·
April 3, 2025
SYDNEY, April 03, 2025 (GLOBE NEWSWIRE) -- Leading online FX and CFD broker Axi has unveiled their new campaign, Four Years. Featuring Manchester City stars, Ruben Dias, Bernardo Silva, and John Stones, the campaign celebrates four years of partnership and …
Axi lanza la campaña ‘Cuatro Años’ con las estrellas del Manchester City
GlobeNewswire
·
April 3, 2025
SYDNEY, April 03, 2025 (GLOBE NEWSWIRE) -- El principal bróker de FX y CFD en línea, Axi, ha desvelado su nueva campaña, Cuatro Años. Con las estrellas del Manchester City, Ruben Dias, Bernardo Silva y John Stones, la campaña celebra cuatro años de …
Argella Moves Headquarters to UAE to Support Regional Growth
GlobeNewswire
·
April 3, 2025
DUBAI, United Arab Emirates, April 03, 2025 (GLOBE NEWSWIRE) -- Argella, a global advisory and data-led technology firm has officially relocated its headquarters from London to Dubai. Established in the Meydan Free Zone, the new entity marks a strategic …
Crushon AI Boosts NSFW AI and AI Girlfriend Capabilities
GlobeNewswire
·
April 3, 2025
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Crushon AI, a prominent conversational AI platform, announced a new release today, dramatically enhancing its NSFW AI and AI Girlfriend functionality. The release is a response to the growing demand globally for …
Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel
GlobeNewswire
·
April 3, 2025
CHF 27 million investment significantly bolsters Boehringer's ADC portfolio, driven by its subsidiary, NBE Therapeutics, to achieve the company’s aim of transforming the lives of people with cancer. Basel, Switzerland, Thursday, 03.04.2025 – Today NBE …
Vítej, budoucnosti. Endoskopický systém ELUXEO® 8000
GlobeNewswire
·
April 3, 2025
RATINGEN, Německo, April 03, 2025 (GLOBE NEWSWIRE) -- Tým FUJIFILM Healthcare Europe s potěšením oznamuje evropské uvedení svého pokročilého endoskopického systému ELUXEO® 8000* s novými terapeutickými možnostmi, řízením pracovních postupů a lepší kvalitou …
Welcome, Future. ELUXEO® 8000-Endoskopiesystem
GlobeNewswire
·
April 3, 2025
RATINGEN, Deutschland, April 03, 2025 (GLOBE NEWSWIRE) -- Das Team von FUJIFILM Healthcare Europe freut sich, die Markteinführung von ELUXEO® 8000* in Europa bekannt zu geben, unserem neuen fortschrittlichen Endoskopiesystem mit neuen therapeutischen …
Welcome, Future. Sistema endoscopico ELUXEO® 8000
GlobeNewswire
·
April 3, 2025
RATINGEN, Germania, April 03, 2025 (GLOBE NEWSWIRE) -- Il team FUJIFILM Healthcare Europe è entusiasta di annunciare l’uscita in Europa di ELUXEO® 8000*, il nostro nuovo sistema endoscopico avanzato che include nuove capacità terapeutiche, gestione del …
Welcome, Future (Bem-vindo, futuro). Sistema de endoscopia ELUXEO® 8000
GlobeNewswire
·
April 3, 2025
RATINGEN, Alemanha, April 03, 2025 (GLOBE NEWSWIRE) -- A equipa da FUJIFILM Healthcare Europe tem o prazer de anunciar o lançamento na Europa do ELUXEO® 8000*, o novo sistema de endoscopia avançada com novas capacidades terapêuticas, gestão do fluxo de …
Welcome, Future (Bienvenido, futuro). Sistema de endoscopia ELUXEO® 8000
GlobeNewswire
·
April 3, 2025
RATINGEN, Alemania, April 03, 2025 (GLOBE NEWSWIRE) -- Al equipo de FUJIFILM Healthcare Europe nos complace anunciar el lanzamiento de ELUXEO 8000, nuestro nuevo sistema de endoscopia avanzado con nuevas capacidades terapéuticas, gestión del flujo de …
LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics
GlobeNewswire
·
April 3, 2025
Press release LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics Access to extensive donor pool supports LIfT’s move into the clinic London, 03 April 2025 – LIfT BioSciences, (‘LIfT’ or ‘the …
Welcome, Future. ELUXEO® 8000 Endoscopy System
GlobeNewswire
·
April 3, 2025
RATINGEN, Germany, April 03, 2025 (GLOBE NEWSWIRE) -- The FUJIFILM Healthcare Europe Team are excited to announce the European launch of ELUXEO® 8000*, our new advanced endoscopy system with new therapeutic capabilities, workflow management and improved …
Welcome, Future (Welkom, toekomst). ELUXEO® 8000 Endoscopy-systeem
GlobeNewswire
·
April 3, 2025
RATINGEN, Duitsland, April 03, 2025 (GLOBE NEWSWIRE) -- Het FUJIFILM Healthcare Europe-team kondigt met trots de Europese lancering aan van ELUXEO® 8000*, ons nieuwe geavanceerde endoscopiesysteem met nieuwe therapeutische mogelijkheden, workflowmanagement …
Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines
GlobeNewswire
·
April 3, 2025
Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines Designation granted for warm autoimmune hemolytic anemia and IgG4-related disease Rilzabrutinib is currently under regulatory review in the US, EU and …
Communiqué de presse : Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de deux maladies rares contre lesquelles il n’existe aucun médicament approuvé
GlobeNewswire
·
April 3, 2025
Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de deux maladies rares contre lesquelles il n’existe aucun médicament approuvé Désignation accordée pour l’anémie hémolytique à anticorps chauds et la maladie …
Veteran Banker Joins Avextra’s Supervisory Board
GlobeNewswire
·
April 3, 2025
News Release Dr. Stefan Jentzsch, Partner at the global investment firm Perella Weinberg Partners has been appointed to Avextra’s Supervisory Board, bringing decades of experience in corporate finance, M…
Domenico Carosa Files Early Warning Report with Respect to Common Shares of Banxa Holdings Inc.
GlobeNewswire
·
April 3, 2025
AMSTERDAM, April 02, 2025 (GLOBE NEWSWIRE) -- Domenico Carosa has filed on SEDAR+ (www.sedarplus.com) an early warning report with respect to Common Shares (the “Shares”) of Banxa Holdings Inc. (the “Issuer” or “Banxa”) disposed and/or acquired by Domenico …